Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy. GJSFR [Internet]. 2024 Nov. 14 [cited 2026 Feb. 4];24(G1):1-3. Available from: https://testing.journalofscience.org/index.php/GJSFR/article/view/102918